We don't know whether the most recent response to this request contains information or not – if you are James Kelly please sign in and let everyone know.

Co-proxamol Importers From May 2008 to February 2018

We're waiting for James Kelly to read a recent response and update the status.

Dear Medicines and Healthcare products Regulatory Agency,

Please can you reveal the identity (names) of all the licenced importers of Co-proxamol from May 2008 to February 2018?

Yours faithfully,

James Kelly

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

Our Ref: FOI 21/376

Dear James Kelly,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 8 April 2021.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Kind Regards,

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

Dear Mr Kelly,

Ref: FOI 21/376 , FOI 21/465

Thank you for your communication to the MHRA in relation to a Freedom of Information request for:

1.My request relates to the information you provided on 4th September 2018 "Co proxamol information 2007 2018.xls file" which disclosed every application to import Co-proxamol with the importer names redacted.
As you're aware the ICO Commissioner considered whether the MHRA had correctly applied section 41 and/or 43 of the FOI act to withhold the names of the licenced importers and decided you hadn’t, as you hold all the requested information you should disclose this information immediately.
Please can you remove all the redactions on this xls file you previously supplied?

2.Please can you reveal the identity (names) of all the licenced importers of Co-proxamol from May 2008 to February 2018?

We have responded to the request previously and hold no further information. The FOIA places a general duty on public authorities to give access to official information. However, it also provides an exemption from that duty for requests that are repeated under section 14 of the Act.

If you have a query about this letter, please do not hesitate to contact us at IE&[email address]

If you are unhappy with our decision, you may ask for it to be reviewed. That review will be undertaken by a senior member of the Agency who has not previously been involved in your request. If you wish to pursue that option please email: [MHRA request email]

Due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices.

After that, if you remain dissatisfied, you may write to the Information Commissioner at; The Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire
SK9 5AF.
They will make a decision on whether or not we have interpreted the FOIA correctly in handling your request.

Yours sincerely

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections

Dear Medicines and Healthcare products Regulatory Agency,
The information you have previously provided is not date specific. In order for me to identify the importers who are seriously overcharging the NHS I need to have date specific information. I would be grateful if you could supply the importer names for the following Month / Year dates: -

May/08, May/08, Oct/08, Oct/08, Oct/08, Oct/08, Nov/08, Mar/09, Apr/09, Apr/09, May/09, Jul/09, Jul/09, Aug/09, Sep/09, Sep/09, Oct/09, Nov/09, Dec/09, Jan/10, Jan/10, Jan/10, Feb/10, Feb/10, Feb/10, Mar/10, Apr/10 Apr/10, Apr/10, Apr/10, May/10, May/10, Aug/10, Sep/10, Oct/10, Nov/10, Dec/10, Jan/11, Jan/11, Jan/11, Feb/11, Mar/11, May/11, Sep/11, Oct/11, Nov/11, Nov/11, Nov/11, Feb/12, May/12, Jun/12, Nov/12, Mar/13, Apr/13, Oct/13, May/14, Apr/15, Oct/15, Oct/15, Dec/15, Jan/16, Feb/16, Mar/16, Mar/16 Apr/16, Apr/16, May/16, Dec/17, Feb/18

Yours faithfully,
James Kelly

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

 

 

Our Ref: FOI 21/506

       

Dear James Kelly

       

RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

        

Thank you for your enquiry which we received on 7^th May 2021.

  

I confirm that your request is now being handled under the Freedom of
Information Act and you should receive a reply within 20 working days from
our date of receipt. 

 

If you need to contact us again about this request, please quote the
reference number above.

 

Please be aware that we publish FOIs replies and these are redacted and
are located on our website at the following link below.

[1]https://www.gov.uk/government/collection...

        

Kind Regards,

 

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 0203 080 6000

 

 

 

show quoted sections

Zdravka Ivanova, Medicines and Healthcare products Regulatory Agency

7^th June 2021

 

Dear Mr Kelly,

 

Ref: FOI 21/506

 

Thank you for your communication to the MHRA in relation to a Freedom of
Information request for the importer names for the following Month / Year
dates: -

May/08, May/08, Oct/08, Oct/08, Oct/08, Oct/08, Nov/08, Mar/09, Apr/09,
Apr/09, May/09, Jul/09, Jul/09, Aug/09, Sep/09, Sep/09, Oct/09, Nov/09,
Dec/09, Jan/10, Jan/10, Jan/10, Feb/10, Feb/10, Feb/10, Mar/10, Apr/10
Apr/10, Apr/10, Apr/10, May/10, May/10, Aug/10, Sep/10, Oct/10, Nov/10,
Dec/10, Jan/11, Jan/11, Jan/11, Feb/11, Mar/11, May/11, Sep/11, Oct/11,
Nov/11, Nov/11, Nov/11, Feb/12, May/12, Jun/12, Nov/12, Mar/13, Apr/13,
Oct/13, May/14, Apr/15, Oct/15, Oct/15, Dec/15, Jan/16, Feb/16, Mar/16,
Mar/16 Apr/16, Apr/16, May/16, Dec/17, Feb/18

 

We have responded to the request previously and hold no further
information.  The FOIA places a general duty on public authorities to give
access to official information.  However, it also provides an exemption
from that duty for requests that are repeated under section 14 of the Act.

 

If you have a query about this letter, please do not hesitate to contact
us at [1]IE&[email address]

 

If you are unhappy with our decision, you may ask for it to be reviewed.
That review will be undertaken by a senior member of the Agency who has
not previously been involved in your request. If you wish to pursue that
option please email: [2][MHRA request email]

 

Due to the ongoing Covid-19 situation, we are not able to accept delivery
of any documents or correspondence by post or courier to any of our
offices.

 

After that, if you remain dissatisfied, you may write to the Information
Commissioner at; The Information Commissioner’s Office Wycliffe House
Water Lane Wilmslow Cheshire

SK9 5AF.

They will make a decision on whether or not we have interpreted the FOIA
correctly in handling your request.

 

Yours sincerely

 

IE&S FOI Team

MHRA

Inspection, Enforcement and Standards

cc FOI_Policy

 

show quoted sections

Zdravka Ivanova, Medicines and Healthcare products Regulatory Agency

Zdravka Ivanova would like to recall the message, "FOI 21/506".

show quoted sections

IE&SFOI, Medicines and Healthcare products Regulatory Agency

7^th June 2021

 

Dear Mr Kelly,

 

Ref: FOI 21/506

 

Thank you for your communication to the MHRA in relation to a Freedom of
Information request for the importer names for the following Month / Year
dates: -

May/08, May/08, Oct/08, Oct/08, Oct/08, Oct/08, Nov/08, Mar/09, Apr/09,
Apr/09, May/09, Jul/09, Jul/09, Aug/09, Sep/09, Sep/09, Oct/09, Nov/09,
Dec/09, Jan/10, Jan/10, Jan/10, Feb/10, Feb/10, Feb/10, Mar/10, Apr/10
Apr/10, Apr/10, Apr/10, May/10, May/10, Aug/10, Sep/10, Oct/10, Nov/10,
Dec/10, Jan/11, Jan/11, Jan/11, Feb/11, Mar/11, May/11, Sep/11, Oct/11,
Nov/11, Nov/11, Nov/11, Feb/12, May/12, Jun/12, Nov/12, Mar/13, Apr/13,
Oct/13, May/14, Apr/15, Oct/15, Oct/15, Dec/15, Jan/16, Feb/16, Mar/16,
Mar/16 Apr/16, Apr/16, May/16, Dec/17, Feb/18

 

We have responded to the request previously and hold no further
information.  The FOIA places a general duty on public authorities to give
access to official information.  However, it also provides an exemption
from that duty for requests that are repeated under section 14 of the Act.

 

If you have a query about this letter, please do not hesitate to contact
us at [1]IE&[email address]

 

If you are unhappy with our decision, you may ask for it to be reviewed.
That review will be undertaken by a senior member of the Agency who has
not previously been involved in your request. If you wish to pursue that
option please email: [2][MHRA request email]

 

Due to the ongoing Covid-19 situation, we are not able to accept delivery
of any documents or correspondence by post or courier to any of our
offices.

 

After that, if you remain dissatisfied, you may write to the Information
Commissioner at; The Information Commissioner’s Office Wycliffe House
Water Lane Wilmslow Cheshire

SK9 5AF.

They will make a decision on whether or not we have interpreted the FOIA
correctly in handling your request.

 

Yours sincerely

 

IE&S FOI Team

MHRA

Inspection, Enforcement and Standards

cc FOI_Policy

 

 

show quoted sections

Dear Medicines and Healthcare products Regulatory Agency,

Please pass this on to the person who conducts Freedom of Information reviews.

I am writing to request an internal review of Medicines and Healthcare products Regulatory Agency's handling of my FOI request 'Co-proxamol Importers From May 2008 to February 2018'.

Re your response: “We have responded to the request previously and hold no further information. The FOIA places a general duty on public authorities to give access to official information. However, it also provides an exemption from that duty for requests that are repeated under section 14 of the Act.”

My FOI request dated 08th April 2021: Stated “Please can you reveal the identity (names) of all the licenced importers of Co-proxamol from May 2008 to February 2018?”

Your response dated 06th May 2021 did link my new request FOI 21/465 to FOI 21/376. FOI 21/465 was a new request and shouldn’t have been linked to any previous request! This request was clarified again on 07th May 2021 stating the Month/Year dates when importer names were not disclosed!

I believe MHRA can’t continue to refuse naming the importers by using Section 14 rule or claiming the information had previously been disclosed!

MHRA HAVE NOT PREVIOUSLY DISCLOSED THE IMPORTER NAMES FOR THE MONTH/YEAR DATES I PROVIDED IN MY CLARIFICATION DATED 07TH MAY 2021!

My FOI 21/465 request is certainly neither Vexatious or Frivolous it is a genuine request for information to find out which importers were responsible for the vast drain on vital NHS Funds!

MY REASONING WHY MHRA MUST DISCLOSE THE IMPORTER NAMES

Highest and Lowest Prices Paid by CCG’s For Co-proxamol During August 2020.
https://openprescribing.net/national/eng...
CCG - Price per Tablet - Quantity Ordered
NHS Stafford and Surrounds CCG @ £12.85 for 60 Tablets
NHS Herts Valley CCG @ £ 0.97 for 918 Tablets

https://openprescribing.net/national/eng...
The latest published figures are for January 2021. The highest price paid per tablet remained with NHS Stafford and Surrounds CCG at £10.95! The Lowest price paid was NHS Southend CCG at £1.01. During The Last 12 months (Mar '20—Feb '21) NHS CCG's Spent £2,261,377 on Co-proxamol for 9,906 Items!

IT’S APPARENT THAT CO-PROXAMOLREMAINS A MUCH NEEDED MEDICATION AS ALL THE REMAINING NAMED PATENTS WHO HAVE MANAGED TO FIND A CONSCIENTIOUS GP WHO IS WILLING TO CONTINUE PRESCRIBING THE BEST MEDICATION FOR THEIR PATIENT’s THIRTEEN YEARS AFTER THE BAN CAME INTO FORCE DISPITE THE ASTRONOMICAL COST TO THE NHS!

When my 'Named Patient' status was revoked during November 2015 my average dose for Co-proxamol would be six tablets per day / 168 per month. This would equate to the average monthly dose costing NHS Stafford and Surrounds CCG £1738.80 during January 2021! NHS Southend CCG would equate to £169.68 a difference of £1569.12

FORTUNATELY THERE IS A CLOSE EQUIVALENT WHICH HAS BEEN AVAILABLE FOR IMPORT SINCE 2017 ‘PARVON-N’ AT A COST OF JUST £0.006 PENCE PER TABLET! THE ONLY DIFFERENCE COMPARED WITH CO-PROXAMOL IS AN EXTRA 25MG OF PARACETAMOL PER TABLET WHICH IS NEGLIGIBLE AND PROBABLY MORE BENEFICIAL.

https://www.drugsupdate.com/brand/generi...
The link above shows the advertised cost for Parvon-N at just 67.07 Indian Rupee for 100 tablets which equates to £0.66 a consiberable saving for the NHS!

A full history of my FOI request and all correspondence is available on the Internet at this address: https://www.whatdotheyknow.com/request/c...

Yours faithfully,

James Kelly

MHRA Customer Services, Medicines and Healthcare products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

We don't know whether the most recent response to this request contains information or not – if you are James Kelly please sign in and let everyone know.